Foster Jonathan P. — SEC insider filings

SEC reporting owner CIK 1545414. 26 insider filings on record with FilingPulse; latest filed 2026-11-18.

Transaction summary — filings shown

Covers all 26 filings on record, filed 2021-06-21 to 2026-11-18. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
Moleculin Biotech, Inc. (MBRX)Chief Financial Officer203 legs · 592,589 sh · $120,000—60
Empery Digital Inc. (EMPD)Director5——8
Soliton, Inc. (SOLY)Director1——4

Insider filings — Foster Jonathan P.

FiledFormIssuerReported transactionsSource
2026-11-184Moleculin Biotech, Inc. (MBRX)Option exercise (M): 362 · Tax withholding (F): 89 @ $7.14 · Option exercise (M): 362 (derivative) @ $0EDGAR
2026-11-064Moleculin Biotech, Inc. (MBRX)Option exercise (M): 41 · Tax withholding (F): 10 @ $8.46 · Option exercise (M): 41 (derivative) @ $0EDGAR
2026-10-164Moleculin Biotech, Inc. (MBRX)Option exercise (M): 130,000 · Tax withholding (F): 30,485 @ $0.37 · Grant/award (A): 260,000 (derivative) · Grant/award (A): 260,000 (derivative) · Option exercise (M): 130,000 (derivative) @ $0EDGAR
2026-08-054Moleculin Biotech, Inc. (MBRX)Purchase (P): 293,333 · Purchase (P): 879,999 (derivative)EDGAR
2026-06-244Moleculin Biotech, Inc. (MBRX)Option exercise (M): 109 · Tax withholding (F): 31 @ $2.88 · Option exercise (M): 174 · Tax withholding (F): 41 @ $3.12 · Option exercise (M): 109 (derivative) @ $0 · Option exercise (M): 174 (derivative) @ $0EDGAR
2026-02-204Empery Digital Inc. (EMPD)Other (J): 2 (derivative) @ $0 · Other (J): 1 (derivative) @ $0 · Other (J): 1 (derivative) @ $0EDGAR
2025-11-144Moleculin Biotech, Inc. (MBRX)Grant/award (A): 600,000 (derivative) · Grant/award (A): 400,000 (derivative)EDGAR
2025-11-064Moleculin Biotech, Inc. (MBRX)Option exercise (M): 20,625 · Option exercise (M): 5,023 @ $0.50 · Option exercise (M): 20,625 (derivative) @ $0EDGAR
2025-07-214Volcon, Inc. (VLCN)Grant/award (A): 20,000 @ $10 · Grant/award (A): 10,000 (derivative)EDGAR
2025-06-234Moleculin Biotech, Inc. (MBRX)Option exercise (M): 2,711 · Tax withholding (F): 661 @ $0.27 · Option exercise (M): 4,328 · Tax withholding (F): 1,054 @ $0.27 · Purchase (P): 270,270 @ $0.37 · Option exercise (M): 2,711 (derivative) @ $0 · +2 moreEDGAR
2025-06-184Moleculin Biotech, Inc. (MBRX)Option exercise (M): 833 · Tax withholding (F): 203 @ $0.69 · Option exercise (M): 833 (derivative) @ $0EDGAR
2024-11-064Moleculin Biotech, Inc. (MBRX)Grant/award (A): 65,000 (derivative) · Grant/award (A): 82,500 (derivative) · Grant/award (A): 19,180 (derivative)EDGAR
2024-06-254Moleculin Biotech, Inc. (MBRX)Option exercise (M): 4,329 · Tax withholding (F): 1,053 @ $3.74 · Option exercise (M): 4,329 (derivative) @ $0EDGAR
2024-06-214Moleculin Biotech, Inc. (MBRX)Option exercise (M): 2,712 · Tax withholding (F): 636 @ $3.78 · Option exercise (M): 2,712 (derivative) @ $0EDGAR
2024-06-184Moleculin Biotech, Inc. (MBRX)Option exercise (M): 834 · Tax withholding (F): 196 @ $4.14 · Option exercise (M): 834 (derivative) @ $0EDGAR
2023-12-274Moleculin Biotech, Inc. (MBRX)Purchase (P): 28,986 @ $0.69EDGAR
2023-07-144Volcon, Inc. (VLCN)Grant/award (A): 200,000 (derivative) @ $0EDGAR
2023-06-264Moleculin Biotech, Inc. (MBRX)Grant/award (A): 150,000 (derivative) · Grant/award (A): 259,688 (derivative)EDGAR
2023-06-224Moleculin Biotech, Inc. (MBRX)Option exercise (M): 40,667 · Tax withholding (F): 9,676 @ $0.57 · Option exercise (M): 40,667 (derivative) @ $0EDGAR
2023-06-204Moleculin Biotech, Inc. (MBRX)Option exercise (M): 12,500 · Tax withholding (F): 3,044 @ $0.57 · Option exercise (M): 12,500 (derivative) @ $0EDGAR
2023-03-164/AVolcon, Inc. (VLCN)Grant/award (A): 101,250 (derivative) @ $0EDGAR
2022-08-124Volcon, Inc. (VLCN)Grant/award (A): 101,250 (derivative) @ $0EDGAR
2022-06-224Moleculin Biotech, Inc. (MBRX)Grant/award (A): 155,000 (derivative) · Grant/award (A): 162,667 (derivative)EDGAR
2022-06-214Moleculin Biotech, Inc. (MBRX)Option exercise (M): 12,500 · Tax withholding (F): 3,044 @ $1.33 · Option exercise (M): 12,500 (derivative) @ $0EDGAR
2021-12-174Soliton, Inc. (SOLY)Disposition to issuer (D): 30,000 (derivative) · Disposition to issuer (D): 15,000 (derivative) · Disposition to issuer (D): 15,000 (derivative) · Disposition to issuer (D): 12,500 (derivative)EDGAR
2021-06-214Moleculin Biotech, Inc. (MBRX)Grant/award (A): 108,770 (derivative) · Grant/award (A): 50,000 (derivative)EDGAR

FilingPulse's Form 4 archive currently extends back to 2020-09-28 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1545414 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs